CEU 2018 Session

Thank You!

We would like to thank all of our faculty, attendees, supporters, and exhibitors for making CEU Anaheim a tremendous success.

Couldn't make it? Not a problem we have you covered, the 2018 Clinical Endocrinology Update Session Recordings are available.

Complete Your Evaluations and Claim Your CME and MOC

Visit the Center for Learning to complete your evaluation online to claim your CME and MOC points and Access your Certificate of Attendance.

View CEU 2018 Sessions

Sessions recordings from CEU are available for viewing for those who purchased the premium package. If you had not purchased the premium package please visit our online store to hear from renowned endocrinology experts and learn on-the-go with these digital sessions.

How do I...?

CEU 2018 Session

Looking for answers on CEU Miami? Visit the "How do I?" page to find information about the app, where to claim CME for Optional Conference Events, our contact information, and more...

Download the CEU App

Keep the meeting at your fingertips with the CEU 2018 App, featuring the full program, resources, evaluations, & more. Get it on Google Play, Download on the Apple App Store, or access via your laptop.

View Full CEU Anaheim Program

Endocrine Society Meeting Code of Conduct

Disclosures & Disclaimers

EBR (14.25 points) and CEU (21.50 points) are certified for both AMA PRA Category 1 Credit(s)™ and ABIM MOC points.

Save The Date

Support and Exhibition

CEU 2018 Supporters

CEU 2018

This activity was supported by independent educational grants from:

Exhibitors

Alexion Pharmaceuticals (Table 18)—Hypophosphatasia is an inherited, progressive disease with a lifelong impact.HPP is caused by a deficiency in ALP.  It can affect men and women of any age.

Astra Zeneca (Table 16)—AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.

Corcept Therapeutics (Table 3)—Corcept Therapeutics is a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol. Korlym® is the company’s first FDA-approved medication. Korlym inhibits the effects of excess cortisol in patients with hypercortisolism.

Endocrine Society—Visit the Endocrine Society Store to purchase Society publications and merchandise at special CEU pricing. Items available for purchase include ESAP™ 2018, Pediatric ESAP™ 2017-2018, Meet-the-Professor 2018, apparel, and gifts for friends and family. You can also order the CEU 2018 Session Recordings at special attendee prices. Stop by to renew your Society membership for 2019 as well.

Esaote North America (Table #19)—Esaote North America is a global leader in research, production and marketing diagnostic medical equipment with an emphasis on ultrasound and office-based MRI.

Gemini Laboratories, LLC (Table #13)—Unithroid is a prescription synthetic thyroid hormone used to treat hypothyroidism. Unithroid is commercialized by Gemini Laboratories, LLC.

Gundersen Health System (Table 7)—Gundersen Health System, in La Crosse, Wisconsin, invites you to join us in our mission to deliver excellence in patient care, education, and research, and to improve health in the communities we serve. We are a physician-led, teaching organization, employing over 650 medical staff across all medical and surgical specialties.

HRA Pharma (Table 15)— Metopirone® (Metyrapone capsules 250mg) is a diagnostic drug for testing hypothalamic-pituitary ACTH function. Visit http://metopirone.us/ for more information.

Interpace Diagnostics (Table 14)—Interpace Diagnostics is a provider of molecular testing for numerous types of cancer. The Company offers ThyGeNEXT® and ThyraMIR® for indeterminate thyroid nodules; PancraGen® and PanDNA® for indeterminate pancreatic cysts; RespriDx® for differentiating metastasis from new primary lung tumors, and BarreGen® for Barrett’s esophagus, a precursor to esophageal cancer.

Ipsen Biopharmaceuticals (Table 17)—Ipsen is a leading biopharmaceutical group dedicated to improving lives through innovative medicines in oncology , neuroscience and rare diseases.

JDRF (Table 15)—Accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications.

LeanMD (Table 5)—LeanMD can help achieve weight loss that is healthy and sustainable. Our program is founded on evidence-based medicine and scientifically backed nutrition principles.

CEU 2018

Novo Nordisk (Tables 10 & 11)—Novo Nordisk, a global health care company, is committed to discovering and developing innovative medicines to help people living with diabetes lead longer, healthier lives.

Pfizer (Table 8)—Our purpose is grounded in our commitment to fund programs that provide public benefit, advance medical care and improve patient outcomes. Our belief is that all people deserve to live healthy lives. This drives our desire to provide access to medicines that are safe, effective, and affordable.

Prader-Willi California Foundation —The success of people with Prader-Willi syndrome depends greatly upon the knowledge and support of the community around them. The Prader-Willi California Foundation provides individuals with PWS, their families and professionals with a state network of information, advocacy and support services.

Radius Health (Table 1)—Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in the areas of osteoporosis and oncology. For more information, please visit www.radiuspharm.com.

Shire (Table 9)—Natpara is a parathyroid hormone indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.

Strongbridge BioPharma (Table 6)—Macrilen is the first and only FDA approved oral test for the diagnosis of Adult Growth Hormone Deficiency (AGHD).

Ultragenyx (Table 2)—Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases.

Valeritas (Wearable Insulin Delivery Device) (Table 20)—We are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies.